FOXO4-DRI

FOXO4-DRI Research Peptide

FOXO4-DRI is an experimental peptide studied in cellular senescence research. The compound is designed to interfere with the interaction between FOXO4 and p53, a signaling relationship involved in the survival of senescent cells.

Pure Axis Peptides provides FOXO4-DRI as a research-use material for qualified laboratory and scientific investigations into cellular senescence, apoptosis, molecular signaling, and related areas of aging biology.

What Is FOXO4-DRI?

FOXO4-DRI is a D-retro-inverso peptide derived from a FOXO4 interaction region. Researchers developed the peptide as a molecular tool for investigating the FOXO4-p53 interaction and its role in maintaining senescent-cell viability.

In foundational research, FOXO4-DRI disrupted the FOXO4-p53 interaction and promoted p53-dependent apoptosis in senescent cells. Experimental work also reported preferential effects on senescent cells compared with non-senescent cells in cellular models.

FOXO4-DRI and Cellular Senescence Research

Cellular senescence is a biological state in which cells permanently reduce their proliferative activity while remaining metabolically active. Senescent cells can also produce signaling molecules associated with the senescence-associated secretory phenotype (SASP).

FOXO4-DRI has become an important research tool for investigating whether disrupting survival pathways in senescent cells can alter cellular and tissue-level outcomes.

Research areas associated with FOXO4-DRI include:

• Cellular senescence
• Senescent-cell biology
• FOXO4-p53 signaling
• Apoptosis research
• Senolytic peptide research
• Aging and longevity biology
• Molecular signaling
• Tissue homeostasis
• Experimental regenerative biology

FOXO4-DRI Mechanism of Research Interest

FOXO4 can interact with p53 within the nucleus of senescent cells. Research indicates that FOXO4-DRI can interfere with this interaction, changing p53 localization and promoting apoptotic signaling in experimental senescent-cell models.

This mechanism makes FOXO4-DRI particularly relevant to researchers investigating how protein-protein interactions regulate cellular survival.

More recent structural research has further examined how FOXO4-DRI interacts with the p53 transactivation domain, providing additional molecular insight into the peptide’s mechanism.

FOXO4-DRI in Preclinical Research

FOXO4-DRI has been investigated in animal models as well as cell-based systems. Studies have examined senescent-cell clearance and tissue-level effects in aging-related experimental models.

More recent preclinical research has investigated FOXO4-DRI in specific biological systems, including endothelial-cell senescence and aged Leydig-cell models. These studies remain preclinical and should not be interpreted as evidence of established clinical efficacy in humans.

For researchers interested in the underlying literature, PubMed’s FOXO4-DRI research provides access to published studies and related scientific records.

Research Applications

FOXO4-DRI may be useful as an experimental tool for researchers studying:

Cellular Senescence: Investigating molecular mechanisms that maintain senescent-cell survival.

FOXO4-p53 Signaling: Examining protein-protein interactions involving FOXO4 and p53.

Apoptosis: Studying pathways associated with programmed cell death in senescent cells.

Senolytic Research: Investigating compounds designed to selectively affect senescent-cell populations.

Aging Biology: Exploring cellular mechanisms associated with aging and tissue homeostasis.

Explore Related Research Peptides

Researchers investigating FOXO4-DRI can explore the wider Peptides collection for additional experimental compounds.

For compounds spanning multiple research categories, visit the Research Chemicals collection.

You can also browse the Shop All Products page to explore the complete Pure Axis Peptides catalog.

Research Use Only

FOXO4-DRI supplied by Pure Axis Peptides is intended strictly for laboratory and scientific research. It is not intended for human consumption, self-administration, diagnosis, treatment, cure, or prevention of any disease or medical condition. FOXO4-DRI remains an experimental research compound, and preclinical findings should not be interpreted as established human clinical outcomes.

Internal Linking Recommendations

• Peptides → /product-category/peptides/
• Research Chemicals → /product-category/research-chemicals/
• Shop All Products → /shop/

Verify the exact live URLs against the site’s current WooCommerce permalink structure before publishing.

External Scientific References

• PubMed — FOXO4-DRI research: https://pubmed.ncbi.nlm.nih.gov/?term=FOXO4-DRI
• Cell/PMC — Targeted apoptosis of senescent cells: https://pmc.ncbi.nlm.nih.gov/articles/PMC5556182/
• Nature Communications — FOXO4-DRI structural research: https://doi.org/10.1038/s41467-025-60844-9
• PubMed — FOXO4-DRI and endothelial-cell senescence: https://pubmed.ncbi.nlm.nih.gov/41625068/
• PubMed — FOXO4-DRI and aged Leydig-cell research: https://pubmed.ncbi.nlm.nih.gov/39025385/

Product Tags

FOXO4-DRI, FOXO4 DRI, FOXO4 Peptide, FOXO4-DRI Peptide, FOXO4 Research Peptide, Senolytic Peptide, Senolytic Research, Cellular Senescence, Senescent Cells, FOXO4 p53, FOXO4 p53 Interaction, p53 Research, Apoptosis Research, Aging Research, Longevity Research, Cellular Aging, Peptide Research, Laboratory Research, Research Peptide, Experimental Peptide